Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann Godet

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|January 7, 2017
Jeanne Galaine, Yann Godet, Olivier Adotévi
Oncoimmunology|December 25, 2012
Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?Yann Godet, Magalie Dosset, Christophe Borg, et al.
Vaccines|September 10, 2015
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer VaccineJeanne Galaine, Christophe Borg, Yann Godet, et al.
Journal of Translational Medicine|January 7, 2021
Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1)Patricia Mercier-Letondal, Chrystel Marton, Yann Godet, et al.
Cancer Gene Therapy|April 12, 2024
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapyValentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cellular Immunology|March 7, 2021
An unmet need: Harmonization of IL-7 and IL-15 combination for the ex vivo generation of minimally differentiated T cellsChrystel Marton, Patricia Mercier-Letondal, Jeanne Galaine, et al.
Oncoimmunology|June 27, 2013
Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccinationMagalie Dosset, Charline Vauchy, Laurent Beziaud, et al.
Cancer Immunology, Immunotherapy : CII|December 22, 2007
A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytesPierre Larrieu, Virginie Renaud, Yann Godet, et al.
Parasite Immunology|March 15, 2020
Echinococcus multilocularis vesicular fluid induces the expression of immune checkpoint proteins in vitroAnne-Pauline Bellanger, Sandra Courquet, Jean-René Pallandre, et al.
Human Vaccines & Immunotherapeutics|January 30, 2013
Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccineOlivier Adotévi, Magalie Dosset, Jeanne Galaine, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|January 7, 2017
Jeanne Galaine, Yann Godet, Olivier Adotévi
Oncoimmunology|December 25, 2012
Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?Yann Godet, Magalie Dosset, Christophe Borg, et al.
Vaccines|September 10, 2015
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer VaccineJeanne Galaine, Christophe Borg, Yann Godet, et al.
Journal of Translational Medicine|January 7, 2021
Validation of a method evaluating T cell metabolic potential in compliance with ICH Q2 (R1)Patricia Mercier-Letondal, Chrystel Marton, Yann Godet, et al.
Cancer Gene Therapy|April 12, 2024
CRISPR-Cas gene knockouts to optimize engineered T cells for cancer immunotherapyValentine De Castro, Jeanne Galaine, Romain Loyon, et al.
Cellular Immunology|March 7, 2021
An unmet need: Harmonization of IL-7 and IL-15 combination for the ex vivo generation of minimally differentiated T cellsChrystel Marton, Patricia Mercier-Letondal, Jeanne Galaine, et al.
Oncoimmunology|June 27, 2013
Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccinationMagalie Dosset, Charline Vauchy, Laurent Beziaud, et al.
Cancer Immunology, Immunotherapy : CII|December 22, 2007
A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytesPierre Larrieu, Virginie Renaud, Yann Godet, et al.
Parasite Immunology|March 15, 2020
Echinococcus multilocularis vesicular fluid induces the expression of immune checkpoint proteins in vitroAnne-Pauline Bellanger, Sandra Courquet, Jean-René Pallandre, et al.
Human Vaccines & Immunotherapeutics|January 30, 2013
Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccineOlivier Adotévi, Magalie Dosset, Jeanne Galaine, et al.
Pageof 6